A wnaiff yr Ysgrifennydd Cabinet gadarnhau a yw'r driniaeth gyfunol o dabrafenib a trametinib i drin gliomas plentyndod ar gael i gleifion sy'n cael eu trin yng Nghymru ar ôl iddi gael ei chymeradwyo'n ddiweddar gan NICE?
Wedi'i ateb gan Ysgrifennydd y Cabinet dros Iechyd a Gofal Cymdeithasol | Wedi'i ateb ar 29/10/2024
All treatments recommended by NICE or our own appraisal body the All Wales Medicines Strategy Group (AWMSG) are available to prescribe in Wales.
Dabrafenib and trametinib was made available for treating BRAF V600E mutation-positive glioma in children and young people aged 1 year and over (TA977) on 3 July via the New Treatment Fund.